04/03/2024
7:14 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:05 PM | Mersana Therapeutics (Filer)
| Form POS AM | |
02/28/2024
7:49 AM | Mersana Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
7:43 AM | Mersana Therapeutics (Filer)
| Form POSASR | |
02/28/2024
6:07 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Mersana Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
7:43 PM | Mersana Therapeutics (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
|
02/14/2024
5:55 PM | Mersana Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:20 AM | Avoro Capital Advisors LLC (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:22 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G | |
01/22/2024
12:36 PM | Mersana Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
4:16 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:18 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:18 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:19 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:19 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:20 PM | Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Mersana Therapeutics (Issuer)
MISRA TUSHAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
8:12 PM | Mersana Therapeutics (Subject)
Protopapas Anna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:13 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:13 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:14 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:42 PM | Mersana Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024
7:06 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:14 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:42 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:18 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:12 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:26 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:27 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:29 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:30 PM | Dere Willard H (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:31 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
7:27 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
4:59 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:51 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:53 PM | Mersana Therapeutics (Issuer)
MISRA TUSHAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:55 PM | Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:57 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
09/07/2023
4:46 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
6:08 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
7:53 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
7:04 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
12:55 PM | EcoR1 Capital, LLC (Reporting)
Mersana Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/27/2023
4:11 PM | EcoR1 Capital, LLC (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G | |
07/27/2023
6:32 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
3:23 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:24 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:18 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:38 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
3:15 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:16 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:17 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:19 PM | Diaz Allene M. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
7:55 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:11 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
5:00 AM | Mersana Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023
5:02 AM | Mersana Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023
5:04 AM | Mersana Therapeutics (Filer)
| Form ARS | |
